Publications
- Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)2012 | First Faculty of Medicine
- The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)2012 | First Faculty of Medicine
- Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA study)2010 | First Faculty of Medicine
- Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)2010 | First Faculty of Medicine
- An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial2010 | First Faculty of Medicine
- Plasma concentration of Amino-Terminal Pro-Brain natriuretic peptide in chronic heart failure: Prediction of cardiovascular events and interaction with the effects of rosuvastatin a report from CORONA2009 | First Faculty of Medicine
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) A Retrospective Analysis2009 | First Faculty of Medicine
- Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide2009 | First Faculty of Medicine
- Deset nejdůležitějších událostí v kardiologii v roce 2022 podle Johna Mandroly2023 | First Faculty of Medicine
- Summary of 2021 ESC Guidelines for the diagnosis and treatment of heart failure2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
Loading network view...